Trials / Completed
CompletedNCT04142125
Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease
Combination Anti-thrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease: Protocol for a Pilot Randomized Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Population Health Research Institute · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
CATIS-ICAD is a clinical pilot study in which patients who have had a recent ischemic stroke, that is a stroke caused by a blood clot or a narrowing of the blood vessels in the brain due to the build up of plaque, will be randomly assigned to receive either low-dose rivaroxaban + aspirin or aspirin alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rivaroxaban 2.5 Mg Oral Tablet bid | Pts will receive rivaroxaban + aspirin |
| DRUG | Acetylsalicyclic acid 81 mg tablet qd | Pts will receive ASA |
Timeline
- Start date
- 2020-02-03
- Primary completion
- 2023-09-18
- Completion
- 2023-09-18
- First posted
- 2019-10-29
- Last updated
- 2023-09-26
Locations
10 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT04142125. Inclusion in this directory is not an endorsement.